Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Chronic Pancreatitis I: Introduction

Chronic Pancreatitis I: Introduction

The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...

Chronic Pancreatitis I: Introduction

Chronic Pancreatitis I: Introduction

Chronic pancreatitis is a long-standing, relapsing inflammation of the pancreas, characterized by irreversible damage to the gland. It results in progressive destruction of the pancreatic parenchyma, fibrosis, and eventual loss of both exocrine and endocrine function. The disease may evolve gradually after multiple episodes of acute pancreatitis or develop independently.EtiologyChronic pancreatitis can arise from a variety of causes:Alcohol use is the leading cause, accounting for 70–80% of...

Chronic Pancreatitis II: Pathophysiology

Chronic Pancreatitis II: Pathophysiology

Chronic pancreatitis is a progressive and irreversible inflammation of the pancreas, most often caused by long-term alcohol abuse, but it can also be related to ductal obstruction, smoking, or genetic factors.Chronic pancreatitis occurs when the pancreas is repeatedly exposed to harmful agents like alcohol, smoking, ductal obstruction, or genetic predisposition. These factors lead to the release of toxic metabolites and inflammatory cytokines, sustaining chronic inflammation in the pancreatic...

Acute Pancreatitis I: Introduction

Acute Pancreatitis I: Introduction

Acute pancreatitis is the sudden inflammation of the pancreas caused by the early activation of digestive enzymes, leading to the autodigestion of pancreatic tissue. This results in local inflammation and, in severe cases, systemic complications.EtiologyUnderstanding the underlying causes is crucial, as identifying the etiology guides treatment and anticipates complications. Acute pancreatitis can be triggered by various factors, typically grouped into the following clinical categories.Biliary...

Acute Pancreatitis I: Introduction

Acute Pancreatitis I: Introduction

Pancreatitis is inflammation of the pancreas, an organ located behind the stomach. It can be either acute or chronic.
Acute pancreatitis is characterized by rapid inflammation of the pancreas, often caused by factors like gallstone blockage or excessive alcohol consumption. Chronic pancreatitis, on the other hand, is a slow, progressive inflammation that may result from long-term alcohol abuse, obstructions in the pancreatic duct, or genetic factors.
The causes of acute pancreatitis include:

Chronic Pancreatitis II: Collaborative Care

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Pancreatic Cancer: Translating Tumor Biology into Actionability.

Cancer discovery·2026

Same author

Hypochlorous acid testing studies: elective surgeries (Hypoclates:Elective).

BMJ open·2026

Same author

Molecular and Clinical Determinants of Targeted Therapy Treatment in Biliary Tract Cancer.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026

Same author

Phase I trial of intravenous VCN-01 oncolytic adenovirus and durvalumab in patients with head and neck metastatic squamous cell carcinoma refractory to immunotherapy.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026

Same author

HYPOChLorous Acid TEsting Studies in elective groin VASCULAR surgery (HYPOCLATES:VASCULAR): protocol for an ambispective cohort study evaluating a standard change to hypochlorous acid lavage in patients undergoing elective groin vascular surgery.

BMC surgery·2026

Same author

A targetable opioid/cancer associated fibroblast axis drives extracellular matrix remodeling and tumor aggressiveness in pancreatic cancer.

bioRxiv : the preprint server for biology·2026

Same journal

Primary aldosteronism.

Nature reviews. Disease primers·2026

Same journal

Primary aldosteronism.

Nature reviews. Disease primers·2026

Same journal

Buruli ulcer in Africa: between innovation and pragmatism.

Nature reviews. Disease primers·2026

Same journal

Author Correction: Atopic dermatitis.

Nature reviews. Disease primers·2026

Same journal

Integrating sexual health into care for patients with cancer and chronic illness.

Nature reviews. Disease primers·2026

Same journal

Chronic graft-versus-host disease.

Nature reviews. Disease primers·2026

See all related articles

Search research articles

Related Experiment Video

Updated: May 9, 2026

Reprogramming Pancreatic Ductal Adenocarcinoma to Pluripotency

Reprogramming Pancreatic Ductal Adenocarcinoma to Pluripotency

Published on: February 2, 2024

Pancreatic cancer.

Susanne Roth^1,2, Minoti Apte³, Vinod P Balachandran^4,5

¹Department of Surgery, Heidelberg University Hospital, Heidelberg, Germany.

Nature Reviews. Disease Primers

|May 7, 2026

Summary

This summary is machine-generated.

Pancreatic cancer (PDAC) treatment is advancing with precision medicine, RNA vaccines, and surgical innovations. These strategies aim to improve outcomes and transform PDAC into a manageable disease.

Related Experiment Videos

Last Updated: May 9, 2026

Reprogramming Pancreatic Ductal Adenocarcinoma to Pluripotency

Reprogramming Pancreatic Ductal Adenocarcinoma to Pluripotency

Published on: February 2, 2024

Area of Science:

Oncology
Surgical Oncology
Immunotherapy

Background:

Pancreatic ductal adenocarcinoma (PDAC) is a highly lethal cancer with poor prognosis.
Limited therapeutic success and late diagnosis are key challenges in managing PDAC.

Purpose of the Study:

To review recent advances in pancreatic cancer treatment.
To highlight emerging frontiers in immunotherapy and precision medicine for PDAC.
To discuss innovations in surgical techniques and multidisciplinary approaches.

Main Methods:

Review of multiagent chemotherapy, personalized RNA vaccines, and KRAS-directed agents.
Analysis of multimodal treatment regimens and surgical innovations (vessel-oriented, minimally invasive).
Exploration of multidisciplinary, biology-guided strategies for resectability and therapy sequencing.
Discussion of tumor microenvironment, early detection, AI-assisted imaging, and liquid biopsy.

Main Results:

Multiagent chemotherapy has improved outcomes across disease stages.
Precision medicine, RNA vaccines, and KRAS-directed agents are emerging treatment paradigms.
Surgical innovations enhance resection rates and convert unresectable tumors to resectable.
Multidisciplinary strategies are increasingly defining resectability and therapy sequencing.

Conclusions:

Advances in systemic therapies, surgical techniques, and early detection offer a framework for improved pancreatic cancer management.
Targeting the tumor microenvironment and utilizing precision therapeutics are crucial for overcoming resistance.
The convergence of insights provides hope for transforming PDAC into a more manageable condition.